Búsqueda | Portal de Búsqueda de la BVS España

1.

Shared and distinct mechanisms of UBA1 inactivation across different diseases.

Collins, Jason C; Magaziner, Samuel J; English, Maya; Hassan, Bakar; Chen, Xiang; Balanda, Nicholas; Anderson, Meghan; Lam, Athena; Fernandez-Pol, Sebastian; Kwong, Bernice; Greenberg, Peter L; Terrier, Benjamin; Likhite, Mary E; Kosmider, Olivier; Wang, Yan; Samara, Nadine L; Walters, Kylie J; Beck, David B; Werner, Achim.

EMBO J; 43(10): 1919-1946, 2024 May.

Artículo en Inglés | MEDLINE | ID: mdl-38360993

2.

Personal omics profiling reveals dynamic molecular and medical phenotypes.

Chen, Rui; Mias, George I; Li-Pook-Than, Jennifer; Jiang, Lihua; Lam, Hugo Y K; Chen, Rong; Miriami, Elana; Karczewski, Konrad J; Hariharan, Manoj; Dewey, Frederick E; Cheng, Yong; Clark, Michael J; Im, Hogune; Habegger, Lukas; Balasubramanian, Suganthi; O'Huallachain, Maeve; Dudley, Joel T; Hillenmeyer, Sara; Haraksingh, Rajini; Sharon, Donald; Euskirchen, Ghia; Lacroute, Phil; Bettinger, Keith; Boyle, Alan P; Kasowski, Maya; Grubert, Fabian; Seki, Scott; Garcia, Marco; Whirl-Carrillo, Michelle; Gallardo, Mercedes; Blasco, Maria A; Greenberg, Peter L; Snyder, Phyllis; Klein, Teri E; Altman, Russ B; Butte, Atul J; Ashley, Euan A; Gerstein, Mark; Nadeau, Kari C; Tang, Hua; Snyder, Michael.

Cell; 148(6): 1293-307, 2012 Mar 16.

Artículo en Inglés | MEDLINE | ID: mdl-22424236

3.

How I reduce and treat posttransplant relapse of MDS.

Mina, Alain; Greenberg, Peter L; Deeg, H Joachim.

Blood; 143(14): 1344-1354, 2024 Apr 04.

Artículo en Inglés | MEDLINE | ID: mdl-38306658

4.

The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes.

DeZern, Amy E; Greenberg, Peter L.

Blood; 142(26): 2258-2267, 2023 12 28.

Artículo en Inglés | MEDLINE | ID: mdl-37562001

5.

Myelodysplastic syndromes, thy name is heterogeneity.

Greenberg, Peter L.

Br J Haematol; 201(3): 381-382, 2023 05.

Artículo en Inglés | MEDLINE | ID: mdl-36683593

6.

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.

Fenaux, Pierre; Platzbecker, Uwe; Mufti, Ghulam J; Garcia-Manero, Guillermo; Buckstein, Rena; Santini, Valeria; Díez-Campelo, María; Finelli, Carlo; Cazzola, Mario; Ilhan, Osman; Sekeres, Mikkael A; Falantes, José F; Arrizabalaga, Beatriz; Salvi, Flavia; Giai, Valentina; Vyas, Paresh; Bowen, David; Selleslag, Dominik; DeZern, Amy E; Jurcic, Joseph G; Germing, Ulrich; Götze, Katharina S; Quesnel, Bruno; Beyne-Rauzy, Odile; Cluzeau, Thomas; Voso, Maria-Teresa; Mazure, Dominiek; Vellenga, Edo; Greenberg, Peter L; Hellström-Lindberg, Eva; Zeidan, Amer M; Adès, Lionel; Verma, Amit; Savona, Michael R; Laadem, Abderrahmane; Benzohra, Aziz; Zhang, Jennie; Rampersad, Anita; Dunshee, Diana R; Linde, Peter G; Sherman, Matthew L; Komrokji, Rami S; List, Alan F.

N Engl J Med; 382(2): 140-151, 2020 01 09.

Artículo en Inglés | MEDLINE | ID: mdl-31914241

7.

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.

Malcovati, Luca; Stevenson, Kristen; Papaemmanuil, Elli; Neuberg, Donna; Bejar, Rafael; Boultwood, Jacqueline; Bowen, David T; Campbell, Peter J; Ebert, Benjamin L; Fenaux, Pierre; Haferlach, Torsten; Heuser, Michael; Jansen, Joop H; Komrokji, Rami S; Maciejewski, Jaroslaw P; Walter, Matthew J; Fontenay, Michaela; Garcia-Manero, Guillermo; Graubert, Timothy A; Karsan, Aly; Meggendorfer, Manja; Pellagatti, Andrea; Sallman, David A; Savona, Michael R; Sekeres, Mikkael A; Steensma, David P; Tauro, Sudhir; Thol, Felicitas; Vyas, Paresh; Van de Loosdrecht, Arjan A; Haase, Detlef; Tüchler, Heinz; Greenberg, Peter L; Ogawa, Seishi; Hellstrom-Lindberg, Eva; Cazzola, Mario.

Blood; 136(2): 157-170, 2020 07 09.

Artículo en Inglés | MEDLINE | ID: mdl-32347921

8.

Recent Clinical and Molecular Advances for the Classification of Myelodysplastic Neoplasms.

DeZern, Amy E; Greenberg, Peter L.

J Natl Compr Canc Netw; 20(12): 1280-1283, 2022 12.

Artículo en Inglés | MEDLINE | ID: mdl-36509078

9.

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.

Greenberg, Peter L; Stone, Richard M; Al-Kali, Aref; Bennett, John M; Borate, Uma; Brunner, Andrew M; Chai-Ho, Wanxing; Curtin, Peter; de Castro, Carlos M; Deeg, H Joachim; DeZern, Amy E; Dinner, Shira; Foucar, Charles; Gaensler, Karin; Garcia-Manero, Guillermo; Griffiths, Elizabeth A; Head, David; Jonas, Brian A; Keel, Sioban; Madanat, Yazan; Maness, Lori J; Mangan, James; McCurdy, Shannon; McMahon, Christine; Patel, Bhumika; Reddy, Vishnu V; Sallman, David A; Shallis, Rory; Shami, Paul J; Thota, Swapna; Varshavsky-Yanovsky, Asya Nina; Westervelt, Peter; Hollinger, Elizabeth; Shead, Dorothy A; Hochstetler, Cindy.

J Natl Compr Canc Netw; 20(2): 106-117, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-35130502

10.

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts.

Zeidan, Amer M; Platzbecker, Uwe; Garcia-Manero, Guillermo; Sekeres, Mikkael A; Fenaux, Pierre; DeZern, Amy E; Greenberg, Peter L; Savona, Michael R; Jurcic, Joseph G; Verma, Amit K; Mufti, Ghulam J; Buckstein, Rena; Santini, Valeria; Shetty, Jeevan K; Ito, Rodrigo; Zhang, Jennie; Zhang, George; Ha, Xianwei; Backstrom, Jay T; Komrokji, Rami S.

Blood; 140(20): 2170-2174, 2022 11 17.

Artículo en Inglés | MEDLINE | ID: mdl-35797468

11.

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.

Valent, Peter; Orazi, Attilio; Savona, Michael R; Patnaik, Mrinal M; Onida, Francesco; van de Loosdrecht, Arjan A; Haase, Detlef; Haferlach, Torsten; Elena, Chiara; Pleyer, Lisa; Kern, Wolfgang; Pemovska, Tea; Vladimer, Gregory I; Schanz, Julie; Keller, Alexandra; Lübbert, Michael; Lion, Thomas; Sotlar, Karl; Reiter, Andreas; De Witte, Theo; Pfeilstöcker, Michael; Geissler, Klaus; Padron, Eric; Deininger, Michael; Orfao, Alberto; Horny, Hans-Peter; Greenberg, Peter L; Arber, Daniel A; Malcovati, Luca; Bennett, John M.

Haematologica; 104(10): 1935-1949, 2019 10.

Artículo en Inglés | MEDLINE | ID: mdl-31048353

12.

Time-dependent changes in mortality and transformation risk in MDS.

Pfeilstöcker, Michael; Tuechler, Heinz; Sanz, Guillermo; Schanz, Julie; Garcia-Manero, Guillermo; Solé, Francesc; Bennett, John M; Bowen, David; Fenaux, Pierre; Dreyfus, Francois; Kantarjian, Hagop; Kuendgen, Andrea; Malcovati, Luca; Cazzola, Mario; Cermak, Jaroslav; Fonatsch, Christa; Le Beau, Michelle M; Slovak, Marilyn L; Levis, Alessandro; Luebbert, Michael; Maciejewski, Jaroslaw; Machherndl-Spandl, Sigrid; Magalhaes, Silvia M M; Miyazaki, Yasushi; Sekeres, Mikkael A; Sperr, Wolfgang R; Stauder, Reinhard; Tauro, Sudhir; Valent, Peter; Vallespi, Teresa; van de Loosdrecht, Arjan A; Germing, Ulrich; Haase, Detlef; Greenberg, Peter L.

Blood; 128(7): 902-10, 2016 08 18.

Artículo en Inglés | MEDLINE | ID: mdl-27335276

13.

Metchnikoff's legacy: the dysplastic nature of innate immunity in myelodysplastic syndromes.

Greenberg, Peter L.

Haematologica; 107(3): 568-569, 2022 03 01.

Artículo en Inglés | MEDLINE | ID: mdl-34348457

14.

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Greenberg, Peter L; Stone, Richard M; Al-Kali, Aref; Barta, Stefan K; Bejar, Rafael; Bennett, John M; Carraway, Hetty; De Castro, Carlos M; Deeg, H Joachim; DeZern, Amy E; Fathi, Amir T; Frankfurt, Olga; Gaensler, Karin; Garcia-Manero, Guillermo; Griffiths, Elizabeth A; Head, David; Horsfall, Ruth; Johnson, Robert A; Juckett, Mark; Klimek, Virginia M; Komrokji, Rami; Kujawski, Lisa A; Maness, Lori J; O'Donnell, Margaret R; Pollyea, Daniel A; Shami, Paul J; Stein, Brady L; Walker, Alison R; Westervelt, Peter; Zeidan, Amer; Shead, Dorothy A; Smith, Courtney.

J Natl Compr Canc Netw; 15(1): 60-87, 2017 01.

Artículo en Inglés | MEDLINE | ID: mdl-28040720

15.

Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.

Pang, Wendy W; Pluvinage, John V; Price, Elizabeth A; Sridhar, Kunju; Arber, Daniel A; Greenberg, Peter L; Schrier, Stanley L; Park, Christopher Y; Weissman, Irving L.

Proc Natl Acad Sci U S A; 110(8): 3011-6, 2013 Feb 19.

Artículo en Inglés | MEDLINE | ID: mdl-23388639

16.

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.

Braulke, Friederike; Müller-Thomas, Catharina; Götze, Katharina; Platzbecker, Uwe; Germing, Ulrich; Hofmann, Wolf-Karsten; Giagounidis, Aristoteles A N; Lübbert, Michael; Greenberg, Peter L; Bennett, John M; Solé, Francesc; Slovak, Marilyn L; Ohyashiki, Kazuma; Le Beau, Michelle M; Tüchler, Heinz; Pfeilstöcker, Michael; Hildebrandt, Barbara; Aul, Carlo; Stauder, Reinhard; Valent, Peter; Fonatsch, Christa; Bacher, Ulrike; Trümper, Lorenz; Haase, Detlef; Schanz, Julie.

Genes Chromosomes Cancer; 54(12): 809-17, 2015 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-26355708

17.

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.

Braulke, Friederike; Platzbecker, Uwe; Müller-Thomas, Catharina; Götze, Katharina; Germing, Ulrich; Brümmendorf, Tim H; Nolte, Florian; Hofmann, Wolf-Karsten; Giagounidis, Aristoteles A N; Lübbert, Michael; Greenberg, Peter L; Bennett, John M; Solé, Francesc; Mallo, Mar; Slovak, Marilyn L; Ohyashiki, Kazuma; Le Beau, Michelle M; Tüchler, Heinz; Pfeilstöcker, Michael; Nösslinger, Thomas; Hildebrandt, Barbara; Shirneshan, Katayoon; Aul, Carlo; Stauder, Reinhard; Sperr, Wolfgang R; Valent, Peter; Fonatsch, Christa; Trümper, Lorenz; Haase, Detlef; Schanz, Julie.

Haematologica; 100(2): 205-13, 2015 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-25344522

18.

Myelodysplastic syndromes, version 2.2015.

Greenberg, Peter L; Stone, Richard M; Bejar, Rafael; Bennett, John M; Bloomfield, Clara D; Borate, Uma; De Castro, Carlos M; Deeg, H Joachim; DeZern, Amy E; Fathi, Amir T; Frankfurt, Olga; Gaensler, Karin; Garcia-Manero, Guillermo; Griffiths, Elizabeth A; Head, David; Klimek, Virginia; Komrokji, Rami; Kujawski, Lisa A; Maness, Lori J; O'Donnell, Margaret R; Pollyea, Daniel A; Scott, Bart; Shami, Paul J; Stein, Brady L; Westervelt, Peter; Wheeler, Benton; Shead, Dorothy A; Smith, Courtney.

J Natl Compr Canc Netw; 13(3): 261-72, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25736003

19.

The classical nature of distinctive CMML monocytes.

Greenberg, Peter L.

Blood; 129(13): 1745-1746, 2017 03 30.

Artículo en Inglés | MEDLINE | ID: mdl-28360359

20.

Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes.

Raval, Aparna; Sridhar, Kunju J; Patel, Shripa; Turnbull, Brit B; Greenberg, Peter L; Mitchell, Beverly S.

Blood; 120(24): 4812-8, 2012 Dec 06.

Artículo en Inglés | MEDLINE | ID: mdl-23071274

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Shared and distinct mechanisms of UBA1 inactivation across different diseases.

Personal omics profiling reveals dynamic molecular and medical phenotypes.

How I reduce and treat posttransplant relapse of MDS.

The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes.

Myelodysplastic syndromes, thy name is heterogeneity.

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes.

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS.

Recent Clinical and Molecular Advances for the Classification of Myelodysplastic Neoplasms.

NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts.

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.

Time-dependent changes in mortality and transformation risk in MDS.

Metchnikoff's legacy: the dysplastic nature of innate immunity in myelodysplastic syndromes.

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes.

Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group.

Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group.

Myelodysplastic syndromes, version 2.2015.

The classical nature of distinctive CMML monocytes.

Reduced rRNA expression and increased rDNA promoter methylation in CD34+ cells of patients with myelodysplastic syndromes.